Plunkett Research Online: Genetic Technologies Limited

GENETIC TECHNOLOGIES LIMITED (GENE:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women’s health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breas.....



Genetic Technologies Limited
Ticker: GENE
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 384127000
Fax: 61 384127040
Address: 60-66 Hanover Street
Fitzroy, VIC 3065 Australia

Types Of Business
Industry Ranks

Industry NAICS code:

Genetic Testing Products
ContactsDescription
Paul KasianDirector
Grahame LeonardDirector
See More
Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women’s health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breas.....See More See More

Auditor: PricewaterhouseCoopers
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: